Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9139 USD | -0.04% | -14.59% | -32.30% |
Apr. 18 | Top Premarket Decliners | MT |
Apr. 17 | Sector Update: Health Care Stocks Retreating Late Afternoon | MT |
Financials (USD)
Sales 2022 | 822K | Sales 2023 | 3.02M | Capitalization | 3.34M |
---|---|---|---|---|---|
Net income 2022 | -10M | Net income 2023 | -8M | EV / Sales 2022 | 9.4 x |
Net Debt 2022 | 2.57M | Net Debt 2023 | 8.45M | EV / Sales 2023 | 3.9 x |
P/E ratio 2022 |
-0.47
x | P/E ratio 2023 |
-0.26
x | Employees | 28 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.35% |
Latest transcript on INVO Bioscience, Inc.
1 day | -0.04% | ||
1 week | -14.59% | ||
Current month | -8.61% | ||
1 month | -26.30% | ||
3 months | -0.66% | ||
6 months | -50.60% | ||
Current year | -32.30% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Shum
CEO | Chief Executive Officer | 55 | 17-10-10 |
Andrea Goren
DFI | Director of Finance/CFO | 56 | 21-06-13 |
J. Chris Jensen
CTO | Chief Tech/Sci/R&D Officer | - | 20-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Trent Davis
BRD | Director/Board Member | 56 | 19-12-15 |
Barbara Ryan
BRD | Director/Board Member | 64 | 20-09-13 |
Corporate Secretary | 55 | 08-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 0.9139 | -0.04% | 127,945 |
24-05-21 | 0.9143 | -1.58% | 89,645 |
24-05-20 | 0.929 | -5.69% | 106,478 |
24-05-17 | 0.985 | -1.50% | 97,640 |
24-05-16 | 1 | -6.54% | 514,009 |
Delayed Quote Nasdaq, May 22, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-32.30% | 2.51M | |
-4.77% | 182B | |
+4.10% | 114B | |
-3.85% | 67.76B | |
+5.19% | 51.91B | |
+5.54% | 43.23B | |
+6.07% | 41.07B | |
+23.81% | 32.07B | |
+15.86% | 25B | |
-1.95% | 24.55B |
- Stock Market
- Equities
- INVO Stock